Sort
50,496 grants matching “lung cancer”
Phase I/II Trial of ZD1839 and Celecoxib in Ex-Smokers
$477,498Duke University · U01 · FY2005 · CA
The pluripotency regulator Prdm14 initiates cancer by epigenetic mechanisms
$477,421Monica Jean Justice · Baylor College Of Medicine · R01 · FY2013 · CA
Stress and Proliferation States Impact MicroRNA-Mediated Regulation in Cancer
$477,418Phillip A Sharp · Massachusetts Institute Of Technology · R01 · FY2015 · CA
Transforming Growth Factor-Beta Signal Transduction
$477,313Joan Massague · Sloan-Kettering Inst Can Research · R37 · FY2010 · CA
Project 2: Exploiting Labile Iron Pools for Improving NSCLC Therapy Using Pharmacological Ascorbate
$477,283Douglas Robert Spitz · University Of Iowa · P01 · FY2018 · CA
Project 2: Exploiting Labile Iron Pools for Improving NSCLC Therapy Using Pharmacological Ascorbate
$477,283Douglas Robert Spitz · University Of Iowa · P01 · FY2020 · CA
Project 2: Exploiting Labile Iron Pools for Improving NSCLC Therapy Using Pharmacological Ascorbate
$477,283Douglas Robert Spitz · University Of Iowa · P01 · FY2021 · CA
Role of the METTL13 Lysine Methyltransferase in Signaling and Cancer
$477,278Or P. Gozani · Stanford University · R01 · FY2021 · CA
Assessing and Understanding the Impact of Physcial and Biological Factors on
$477,269Radhe Mohan · Massachusetts General Hospital · U19 · FY2017 · CA
Improving Radiologist Detection of Lung Nodules with CAD
$477,237Geoffrey D Rubin · Stanford University · R01 · FY2006 · CA
Vaccine and Drug Combination Therapy for Human Cancers
$477,129James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Epigenetic control of skin homeostasis by the ULK3 nuclear kinase
$477,112Gian Paolo Dotto · Massachusetts General Hospital · R01 · FY2023 · AR
Epigenetic control of skin homeostasis by the ULK3 nuclear kinase
$477,112Gian Paolo Dotto · Massachusetts General Hospital · R01 · FY2021 · AR
Mechanisms of action of the Smyd3 methyltransferase in cancer cells
$477,053Or P. Gozani · Stanford University · R01 · FY2013 · CA
Microscale Radionuclide S-values for αRPT
$477,048Wesley E Bolch · Johns Hopkins University · P01 · FY2023 · CA
Communicating Waterpipe Tobacco Harms to Reduce Use among Young Adults
$477,029Erin L Sutfin · Wake Forest University Health Sciences · R01 · FY2023 · CA
Metastatic Clonal Heterogeneity and its Impact on Melanoma Therapeutic Resistance
$476,960Willy Hugo · University Of California Los Angeles · R01 · FY2020 · CA
Combined Biologic and Radiopharmaceutical Therapy of Breast Cancer
$476,956George Sgouros · Johns Hopkins University · R01 · FY2017 · CA
Molecular Epidemiology of Secondary Lung Cancer
$476,951Peter G. Shields · Georgetown University · R01 · FY2007 · CA
A Regulatory Cascade that Controls Pneumococcal Capsule Biosynthesis
$476,914Andrew T Ulijasz · Loyola University Chicago · R01 · FY2020 · AI
Engineered hybrid aging model for disease progression
$476,827Pinar Zorlutuna · University Of Notre Dame · R01 · FY2023 · CA
Cancer Recurrence: Detection in Administrative Data, Incidence, and Costs
$476,825Michael James Hassett · Dana-Farber Cancer Inst · R01 · FY2016 · CA
Project 3: From Networks and Structures to Hierarchical Whole Cell Models of Cancer
$476,818Trey Ideker · University Of California, San Francisco · U54 · FY2023 · CA
DNA hypermethylation in lung tumors
$476,797Gerd P Pfeifer · Van Andel Research Institute · R01 · FY2021 · CA
DNA hypermethylation in lung tumors
$476,797Gerd P Pfeifer · Van Andel Research Institute · R01 · FY2019 · CA